Frankfurt - Delayed Quote EUR
Intellia Therapeutics, Inc. (38I.F)
6.98
+0.28
+(4.18%)
At close: April 25 at 3:49:30 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-348,880
-348,880
-394,086
-333,287
-225,030
Investing Cash Flow
125,567
125,567
-31,347
160,309
-550,778
Financing Cash Flow
185,747
185,747
130,323
582,955
736,688
End Cash Position
202,787
202,787
240,353
535,463
125,486
Capital Expenditure
-5,778
-5,778
-13,985
-58,390
-12,756
Issuance of Capital Stock
176,899
176,899
119,795
565,789
693,570
Free Cash Flow
-354,658
-354,658
-408,071
-391,677
-237,786
12/31/2021 - 5/12/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
05Y.F Vivoryon Therapeutics N.V.
1.8120
-2.16%
F6T.F Fate Therapeutics, Inc.
1.1715
+2.14%
22UA.F BioNTech SE
87.65
-13.39%
GRCE Grace Therapeutics, Inc.
2.4900
+4.62%
DYN Dyne Therapeutics, Inc.
11.06
-0.45%
TPST Tempest Therapeutics, Inc.
7.76
-3.60%
OCGN Ocugen, Inc.
0.7192
-2.40%
CRSP CRISPR Therapeutics AG
38.27
-2.15%